Zobrazeno 1 - 10
of 12
pro vyhledávání: '"CFR, Code of Federal Regulations"'
Autor:
Paula Pleguezuelos-Beltrán, Patricia Gálvez-Martín, Daniel Nieto-García, Juan Antonio Marchal, Elena López-Ruiz
Publikováno v:
Digibug. Repositorio Institucional de la Universidad de Granada
instname
instname
This research was funded by Fundacion Mutua Madrilena (FMM-AP17196-2019) , the Consejeria de Economia, Conocimiento, Empresas y Universidad de la Junta de Andalucia (ERDF funds, projects B-CTS-230-UGR18, PY18-2470, A-CTS-180-UGR20, SOMM17-6109, PYC20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a8dfaad3702b342e1ea9b8ae754f1da
https://doi.org/10.1016/j.bioactmat.2022.02.023
https://doi.org/10.1016/j.bioactmat.2022.02.023
Autor:
Faiyaz Shakeel, Ehab A. Fouad, Mohammed Alahmed, Ahmad T. Almnaizel, Ibrahim A. Alsarra, Fars K. Alanazi, Doaa H. Alshora, Osaid T. Almeanazel
Publikováno v:
Saudi Pharmaceutical Journal : SPJ
Saudi Pharmaceutical Journal, Vol 28, Iss 5, Pp 565-573 (2020)
Saudi Pharmaceutical Journal, Vol 28, Iss 5, Pp 565-573 (2020)
Obesity is a metabolic disease that affects all ages; it is considered life-threatening condition as it leads to fatal complications such as; cardiovascular diseases and diabetes. The therapeutic options include; life-style modifications, pharmacothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00a07e341f02edee286d429b742183d7
http://europepmc.org/articles/PMC7229319
http://europepmc.org/articles/PMC7229319
Publikováno v:
Mayo Clinic Proceedings
Objective To assess the readability of the informed consent forms from the phase III COVID-19 vaccine trials conducted in the United States. Patients English consent forms utilized for patients in phase III COVID-19 vaccine clinical trials. Consent f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::db5618d85ebd760f9406d14b8fa9cd79
https://pubmed.ncbi.nlm.nih.gov/34226027
https://pubmed.ncbi.nlm.nih.gov/34226027
Autor:
Shinya Yamanaka, Kentaro Azuma
Publikováno v:
Regenerative Therapy
In Japan, a research center network consisting of Kyoto University to provide clinical-grade induced Pluripotent Stem Cells (iPSC) and several major research centers to develop iPSC-based regenerative therapies was formed for the clinical application
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1957840a9fc1e64016dea9e17fb6c65
http://hdl.handle.net/2433/242857
http://hdl.handle.net/2433/242857
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Kniha
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pleguezuelos-Beltrán P; Biopathology and Regenerative Medicine Institute (IBIMER), Centre for Biomedical Research (CIBM), University of Granada, Granada, Spain.; Department of Human Anatomy and Embryology, Faculty of Medicine, University of Granada, Granada, Spain.; BioFab i3D Lab - Biofabrication and 3D (bio)printing Laboratory, Granada, Spain.; Excellence Research Unit 'Modeling Nature' (MNat), University of Granada, Granada, Spain.; Biosanitary Research Institute of Granada (ibs.GRANADA), University Hospitals of Granada - University of Granada, Granada, Spain., Gálvez-Martín P; R&D Human Health, Bioibérica S.A.U, Barcelona, Spain.; Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Granada, Granada, Spain., Nieto-García D; Department of Human Anatomy and Embryology, Faculty of Medicine, University of Granada, Granada, Spain.; BioFab i3D Lab - Biofabrication and 3D (bio)printing Laboratory, Granada, Spain.; Excellence Research Unit 'Modeling Nature' (MNat), University of Granada, Granada, Spain.; Biosanitary Research Institute of Granada (ibs.GRANADA), University Hospitals of Granada - University of Granada, Granada, Spain.; Complex Tissue Regeneration Department, MERLN Institute for Technology Inspired Regenerative Medicine, Universiteitssingel 40, 6229ER Maastricht, the Netherlands., Marchal JA; Biopathology and Regenerative Medicine Institute (IBIMER), Centre for Biomedical Research (CIBM), University of Granada, Granada, Spain.; Department of Human Anatomy and Embryology, Faculty of Medicine, University of Granada, Granada, Spain.; BioFab i3D Lab - Biofabrication and 3D (bio)printing Laboratory, Granada, Spain.; Excellence Research Unit 'Modeling Nature' (MNat), University of Granada, Granada, Spain.; Biosanitary Research Institute of Granada (ibs.GRANADA), University Hospitals of Granada - University of Granada, Granada, Spain., López-Ruiz E; Biopathology and Regenerative Medicine Institute (IBIMER), Centre for Biomedical Research (CIBM), University of Granada, Granada, Spain.; BioFab i3D Lab - Biofabrication and 3D (bio)printing Laboratory, Granada, Spain.; Excellence Research Unit 'Modeling Nature' (MNat), University of Granada, Granada, Spain.; Biosanitary Research Institute of Granada (ibs.GRANADA), University Hospitals of Granada - University of Granada, Granada, Spain.; Department of Health Sciences, University of Jaén, Jaén, Spain.
Publikováno v:
Bioactive materials [Bioact Mater] 2022 Mar 08; Vol. 16, pp. 187-203. Date of Electronic Publication: 2022 Mar 08 (Print Publication: 2022).
Autor:
Almeanazel O; Kayyali Chair for Pharmaceutical Industries, Department of Pharmaceutics, King Saud University, Riyadh, Saudi Arabia., Alanazi F; Kayyali Chair for Pharmaceutical Industries, Department of Pharmaceutics, King Saud University, Riyadh, Saudi Arabia., Alsarra I; Kayyali Chair for Pharmaceutical Industries, Department of Pharmaceutics, King Saud University, Riyadh, Saudi Arabia., Alshora D; Kayyali Chair for Pharmaceutical Industries, Department of Pharmaceutics, King Saud University, Riyadh, Saudi Arabia., Shakeel F; Kayyali Chair for Pharmaceutical Industries, Department of Pharmaceutics, King Saud University, Riyadh, Saudi Arabia., Almnaizel A; Prince Naif for Health Research Center, King Saud University, Riyadh, Saudi Arabia., Alahmed M; Prince Naif for Health Research Center, King Saud University, Riyadh, Saudi Arabia., Fouad E; Kayyali Chair for Pharmaceutical Industries, Department of Pharmaceutics, King Saud University, Riyadh, Saudi Arabia.
Publikováno v:
Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society [Saudi Pharm J] 2020 May; Vol. 28 (5), pp. 565-573. Date of Electronic Publication: 2020 Mar 19.